Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis- platinum

Clinical Cancer Research

Volumn 4, Issue 6, 1998, Pages 1469-1474

  Boku, Narikazu ^a   Chin, Keisho ^a   Hosokawa, Koichi ^a   Ohtsu, Atsushi ^a   Tajiri, Hisao ^a   Yoshida, Shigeaki ^a   Yamao, Takekazu ^b   Kondo, Hitoshi ^b   Shirao, Kuniaki ^b   Shimada, Yasuhiro ^b   Saito, Daizo ^b   Hasebe, Takahiro ^c   Mukai, Kiyoshi ^c   Seki, Shigeki ^d   Saito, Hiroshi ^e   Johnston, Patrick G ^f  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare

^e Yamagata Prefectural Central Hospital

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE; PROTEIN P53; THYMIDYLATE SYNTHASE; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; DETOXIFICATION; DOSE RESPONSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; CISPLATIN; ENDOTHELIAL GROWTH FACTORS; FEMALE; FLUOROURACIL; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LYMPHOKINES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; SURVIVAL RATE; THYMIDYLATE SYNTHASE; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031748465     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ohtsu, A., Shimada, Y., Yoshida, S., Saito, H., Seki, S., Morise, K., and Kurihara, M. Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG). Eur. J. Cancer, 30A: 2091-2093, 1994.
2. Kim, N. K., Park, Y. S., Heo, D. S., Suh, C., Kim, S. Y., Park, K. C., Kang, Y. K., Shin, D. B., Kim, H. T., Kim, H. J., Kang, W. K., Suh, C. I., and Bang, Y. J. A Phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer (Phila.) 71: 3813-3818, 1993.
3. Rougier, P., Ducreux, M., Mahjoubi, M., Pignon, J. P., Bellefqih, S., Oliveria, J., Bognel, C., Lasser, P., Ychou, M., Elias, D., Cvitkovic, E., Armand, J. P., and Droz, J. P. Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A Phase II trial with prognostic factor analysis. Eur. J. Cancer, 30A: 1263-1269, 1994.
4. Lowe, S. W., Ruley, H. E., Jacks, T., and Houseman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
5. Reed, J. C., Kitada, S., Takayama, S., and Miyashita, T. Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines. Ann. Oncol., 5 (Suppl. 1): 61-65, 1994.
6. Lotem, J., and Sachs, L. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemia cells. Cell Growth Differ., 4: 41-47, 1993.
7. Ozols, R. F., O'Dwyer, P. J., Hamilton, T. C., and Young, R. C. The role of glutathione in drug resistance. Cancer Treat. Rev., 17: 45-50, 1990.
8. Teicher, B. A., Holden, S. A., Kelley, M. J., Shea, T. C., Cucchi, C. A., Rosowsky, A., Henner, W. D., and Frei, E., III. Characterization of a human squamous cell line resistant to cis-diammimmine dichloroplatinum (II). Cancer Res., 47: 388-393, 1987.
9. Okuyama, T., Maehara, Y., Endo, K., Baba, H., Adachi, Y., Kuwano, M., and Sugimachi, K. Expression of glutathione S-transferase-π and sensitivity of human gastric cancer cells to cisplatin. Cancer (Phila.), 74: 1230-1236, 1994.
10. Santi, D. V., McHenry, C. S., and Sommer, H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry, 13: 471-481, 1974.
11. Bergh, J., Norberg, T., Sjogren, S., Lindgren, A., and Holmberg, L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat. Med., 1: 1029-1034, 1995.
12. Muro, K., Ohtsu, A., Boku, N., Chin, K., Oda, Y., Fujii, T., Hosokawa, K., Yoshida, S., and Hasebe, T. Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy. Jpn. J. Clin. Oncol., 26: 65-69, 1996.
13. Gasparini, G., Barbareschi, M., Doglioni, C., Palma, P. D., Mauri, F. A., Boracchi, P., Bevilacqua, P., Caffo, O., Morelli, L., Verderio, P., Pezzella, F., and Harris, A. L. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin. Cancer Res., 1: 189-198, 1995.
14. Nishimura, T., Newkirk, K., Sessions, R. B., Andrews, P. A., Trock, B. J., Rasmussen, A. A., Montgomery, E. A., Bischoff, E. K., and Cullen, K. J. Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer. Clin. Cancer Res., 2: 1859-1865, 1996.
15. Johnston, P. G., Fisher, E. R., Rockette, H. E., Fisher, B., Wolkman, N., Drake, J. C., Chabner, B. A., and Allegra, C. J. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J. Clin. Oncol., 12: 2640-2647, 1994.
16. Lenz, H. J., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Groshen, S., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., Garcia, Y., Li, J., and Leichman, L. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J. Clin. Oncol., 14: 176-182, 1996.
17. Ohsaki, S., Toyoshima, E., Fujiuchi, S., Hirata, S., Miyokawa, N., Kubo, Y., and Kikuchi, K. Bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time. Clin. Cancer. Res., 2: 915-920, 1996.
18. Connoly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., and Feder, J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest., 84: 1470-1478, 1989.
19. Dvorak, H. F., Orenstein, N. S., Carvalho, A. C., Churchill, W. H., Dvorak, A. M., Galli, S. J., Feder, J., Bitzer, A. M., Rypysc, J., and Giovinco, P. Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J. Imraunol., 122: 166-174, 1979.
20. WHO. WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48. Geneva: WHO, 1979.
21. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara, 1995.
22. Johnston, P. G., Lenz, H-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichman, L. Thymidylate synthase and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumours. Cancer Res., 55: 1407-1412, 1995.
23. Nabeya, Y., Loganzo, F., Jr., Maslak, P., Lai, L., de Oliveria, A. R., Schwartz, G. K., Blundell, M. L., Altorki, N. K., Kelsen, D. P., and Albino, A. P. The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. Int. J. Cancer, 64: 37-46, 1995.
24. Gilbert, L., Elwood, L. J., Merino, M., Masood, S., Barnes, R., Steinberg, S. M., Lazarous, D. F., Pierce, L., d'Angelo, T., Moscow, J. A., Townsend, A. J., and Cowan, K. H. A pilot study of π-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J. Clin. Oncol., 11: 49-58, 1993.
25. Ali-Osman, F., Brunner, J. M., Kutluk, T. M., and Hess, K. Prognostic significance of glutathione 5-transferase π expression and subcellular localization in human gliomas. Clin. Cancer Res., 3: 2253-2261, 1997.
26. Zhang, H. T., Craft, P., Scott, P. A. E., Ziehe, M., Weich, H. A., Harris, A. L., and Bicknell, R. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J. Natl. Cancer Inst., 87: 213-219, 1995.
27. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest., 95: 1789-1797, 1995.
28. The international non-Hodgkin's lymphoma prognostic factor project. A predictive model for aggressive non-Hodgkin's lymphoma. N. Engl. J. Med., 329: 987-994, 1993.